Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 5000.00 | 1193.65 | 7111.00 | 7218.75 | 0.9851 | 0.9885 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1193.65 | 6898.00 | 7218.75 | 0.9556 | 0.9653 |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 5000.00 | 1193.65 | 7349.00 | 7218.75 | 1.0180 | 1.0138 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 6279.00 | 7218.75 | 0.8698 | 0.8954 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1193.65 | 4010.00 | 7218.75 | 0.5555 | 0.5948 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 6921.00 | 7218.75 | 0.9588 | 0.9678 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 5000.00 | 1193.65 | 7184.00 | 7218.75 | 0.9952 | 0.9963 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7187.00 | 7218.75 | 0.9956 | 0.9966 | |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 5000.00 | 1193.65 | 2312.00 | 7218.75 | 0.3203 | 0.2900 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 7322.00 | 7218.75 | 1.0143 | 1.0110 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 7074.00 | 7218.75 | 0.9800 | 0.9845 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 6387.00 | 7218.75 | 0.8848 | 0.9079 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 5000.00 | 1193.65 | 7233.00 | 7218.75 | 1.0020 | 1.0015 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7389.00 | 7218.75 | 1.0236 | 1.0180 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7311.00 | 7218.75 | 1.0128 | 1.0098 |
| BT-20 | Erlotinib | 1 | uM | 8 | 5000.00 | 1193.65 | 5988.00 | 7218.75 | 0.8295 | 0.8611 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1193.65 | 7103.00 | 7218.75 | 0.9840 | 0.9876 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 5539.00 | 7218.75 | 0.7673 | 0.8060 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 1929.00 | 7218.75 | 0.2672 | 0.2031 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7263.00 | 7218.75 | 1.0061 | 1.0047 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6914.00 | 7218.75 | 0.9578 | 0.9671 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6409.00 | 7218.75 | 0.8878 | 0.9104 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6910.00 | 7218.75 | 0.9572 | 0.9666 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 5000.00 | 1193.65 | 6589.00 | 7218.75 | 0.9128 | 0.9309 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 6314.00 | 7218.75 | 0.8747 | 0.8995 |